AU7412787A - Glycoprotein of human cytomegalovirus - Google Patents

Glycoprotein of human cytomegalovirus

Info

Publication number
AU7412787A
AU7412787A AU74127/87A AU7412787A AU7412787A AU 7412787 A AU7412787 A AU 7412787A AU 74127/87 A AU74127/87 A AU 74127/87A AU 7412787 A AU7412787 A AU 7412787A AU 7412787 A AU7412787 A AU 7412787A
Authority
AU
Australia
Prior art keywords
glycoprotein
human cytomegalovirus
cytomegalovirus
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74127/87A
Inventor
Bernhard Fleckenstein
Michael Mach
Ursula Utz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU7412787A publication Critical patent/AU7412787A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU74127/87A 1986-06-12 1987-06-11 Glycoprotein of human cytomegalovirus Abandoned AU7412787A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3619720 1986-06-12
DE19863619720 DE3619720A1 (en) 1986-06-12 1986-06-12 MAIN GLYCOPROTEIN OF THE HUMAN CYTOMEGALOVIRUS, ITS PRODUCTION AND USE

Publications (1)

Publication Number Publication Date
AU7412787A true AU7412787A (en) 1987-12-17

Family

ID=6302830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74127/87A Abandoned AU7412787A (en) 1986-06-12 1987-06-11 Glycoprotein of human cytomegalovirus

Country Status (4)

Country Link
EP (1) EP0252302A1 (en)
JP (1) JPS62296891A (en)
AU (1) AU7412787A (en)
DE (1) DE3619720A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603640B2 (en) * 1986-11-24 1990-11-22 Children's Hospital Incorporated, The Monoclonal antibodies to glycopeptides of human cytomegalovirus

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162620A (en) * 1986-03-07 2000-12-19 Cogent Limited Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor
US5153311A (en) * 1986-11-24 1992-10-06 The Children's Hospital, Incorporated Immunogenic glycoproteins of human cytomegalovirus gCII
JPH02504551A (en) * 1987-08-07 1990-12-20 ザ・チルドレンズ・ホスピタル，インコーポレイテッド Monoclonal antibody reactive with cytomegalovirus glycoprotein A
DE68929478T2 (en) * 1988-01-29 2004-04-29 Aventis Pasteur Recombinant CMV neutralization proteins
WO1990000062A1 (en) * 1988-07-01 1990-01-11 The Children's Hospital, Incorporated Antibody recognition of fragments from cytomegalovirus
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
DE69027695T2 (en) * 1989-03-24 1997-02-20 Wistar Inst Recombinant cytomegalovirus vaccine
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
US6448389B1 (en) 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
US8741311B2 (en) 2009-03-27 2014-06-03 Academia Sinica Methods and compositions for immunization against virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603640B2 (en) * 1986-11-24 1990-11-22 Children's Hospital Incorporated, The Monoclonal antibodies to glycopeptides of human cytomegalovirus

Also Published As

Publication number Publication date
DE3619720A1 (en) 1987-12-17
EP0252302A1 (en) 1988-01-13
JPS62296891A (en) 1987-12-24

Similar Documents

Publication Publication Date Title
AU5295890A (en) Preparation of functional human factor viii
AU7831787A (en) Improved recombinant expression
AU7184487A (en) Human g-csf protein expression
AU8015587A (en) 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
AU7412787A (en) Glycoprotein of human cytomegalovirus
AU7594787A (en) Preparation of IgE- binding factors
AU590176B2 (en) Preparation of retrovirus-free immunoglobulins
AU590958B2 (en) Formulations of alpha-interferons
AU613543B2 (en) Preparation of halofluorobenzenes
GB8705317D0 (en) Preparation of pharmaceuticals
AU3967889A (en) Immunogenic glycoproteins of human cytomegalovirus gcii
AU7233987A (en) Treatment of osteoporosis
AU4552389A (en) Preparation of n-acyl-aminomethylphosphonates
AU3836489A (en) Treatment of immunodeficiency
AU7082487A (en) Recombinant human b-cell growth factor
GB2198728B (en) Preparation of trifluoromethylbenzonitrile from trifluoromethylbenzaldehyde
AU4664689A (en) Proteolytic fragments obtained from human cytomegalovirus glycoprotein complex i
AU3283789A (en) Immunogenic glycoproteins of human cytomegalovirus
IL82218A0 (en) Preparation of 1-aryl-5-amino-pyrazoles
IL82217A0 (en) Preparation of 1-aryl-5-amino-pyrazoles
GB2196961B (en) Preparation of polyfluoroenolates
IL84778A0 (en) Preparation of mercaptobenzoates
GB8708603D0 (en) Preparation of()-13-norfaranal
GB8601724D0 (en) Application of tetracyano-quinodimethanes
IL83517A (en) Preparation of n-cyano-methylarylcarboxamides